Literature DB >> 16462018

Low catechol-O-methyltransferase activity in the brain and blood pressure regulation.

Mayumi Masuda1, Makoto Tsunoda, Kazuhiro Imai.   

Abstract

Catecholamines (CAs) are important hormones in regulating blood pressure both in centrally and peripheral sympathetic nerve endings. Production of CAs, release and inactivation are three components to regulate CAs level. We have reported that the inactivation of CAs by catechol-O-methyltransferase (COMT) in the liver is important in high blood pressure in spontaneously hypertensive rats (SHR). In the present study, we investigated central role of COMT in hypertension. We investigated COMT activities in cerebral cortex, cerebellum, hippocampus, brain stem, hypophysis, and hypothalamus of SHR and Wistar-Kyoto (WKY) rats. COMT activities were assessed by measuring normetanephrine with the use of norepinephrine as an endogenous substrate. Membrane-bound COMT activities in cerebral cortex were significantly reduced in SHR (19.1+/-1.8 pmol/min/mg protein) compared with WKY rats (25.0+/-3.3 pmol/min/mg protein). The ratio of concentrations of normetanephrine/norepinephrine in cerebral cortex was also lower in SHR than in WKY rats. Our results suggest that there is an association between MB-COMT in cerebral cortex and blood pressure regulation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16462018     DOI: 10.1248/bpb.29.202

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  8 in total

1.  Clitoria ternatea ameliorated the intracerebroventricularly injected streptozotocin induced cognitive impairment in rats: behavioral and biochemical evidence.

Authors:  Jogender Mehla; Monika Pahuja; Pooja Gupta; Shekhar Dethe; Amit Agarwal; Yogendra Kumar Gupta
Journal:  Psychopharmacology (Berl)       Date:  2013-07-06       Impact factor: 4.530

2.  Interaction between the Val158Met catechol-O-methyltransferase gene variant and second-generation antipsychotic treatment on blood pressure in children.

Authors:  A T Cote; C Panagiotopoulos; A M Devlin
Journal:  Pharmacogenomics J       Date:  2014-07-22       Impact factor: 3.550

3.  Brain white matter structure and COMT gene are linked to second-language learning in adults.

Authors:  Ping C Mamiya; Todd L Richards; Bradley P Coe; Evan E Eichler; Patricia K Kuhl
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-13       Impact factor: 11.205

Review 4.  The abnormalities of adrenomedullary hormonal system in genetic hypertension: Their contribution to altered regulation of blood pressure.

Authors:  A Vavřínová; M Behuliak; I Vaněčková; J Zicha
Journal:  Physiol Res       Date:  2021-05-12       Impact factor: 1.881

5.  Effects of the Fourth Ventricle Compression in the Regulation of the Autonomic Nervous System: A Randomized Control Trial.

Authors:  Ana Paula Cardoso-de-Mello-E-Mello-Ribeiro; Cleofás Rodríguez-Blanco; Inmaculada Riquelme-Agulló; Alberto Marcos Heredia-Rizo; François Ricard; Ángel Oliva-Pascual-Vaca
Journal:  Evid Based Complement Alternat Med       Date:  2015-06-14       Impact factor: 2.629

6.  A Novel Sensitive Method to Measure Catechol-O-Methyltransferase Activity Unravels the Presence of This Activity in Extracellular Vesicles Released by Rat Hepatocytes.

Authors:  Enriqueta Casal; Laura Palomo; Diana Cabrera; Juan M Falcon-Perez
Journal:  Front Pharmacol       Date:  2016-12-23       Impact factor: 5.810

7.  A genetic variant in the catechol-O-methyl transferase (COMT) gene is related to age-dependent differences in the therapeutic effect of calcium-channel blockers.

Authors:  Jiayue Xu; Adrian E Boström; Mohamed Saeed; Raghvendra K Dubey; Gérard Waeber; Peter Vollenweider; Pedro Marques-Vidal; Jessica Mwinyi; Helgi B Schiöth
Journal:  Medicine (Baltimore)       Date:  2017-07       Impact factor: 1.889

8.  Pulse Pressure Magnifies the Effect of COMT Val(158)Met on 15 Years Episodic Memory Trajectories.

Authors:  Ninni Persson; Catharina Lavebratt; Anna Sundström; Håkan Fischer
Journal:  Front Aging Neurosci       Date:  2016-03-02       Impact factor: 5.750

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.